Medicine – Causes of Hypokalaemia

Hypokalaemia is a reduction in serum potassium concentration, usually defined as:

K⁺ <3.5 mmol/L.

Potassium is the major intracellular cation and is essential for normal neuromuscular function, skeletal-muscle contraction and cardiac electrical activity. Significant hypokalaemia can therefore cause weakness, paralysis and potentially dangerous cardiac arrhythmias.

The causes can be understood through three major mechanisms:

Decreased potassium intake.

Increased potassium loss from the body.

Redistribution of potassium from extracellular fluid into cells.

1. Decreased Potassium Intake

Reduced dietary potassium intake alone is an:

Uncommon cause of hypokalaemia.

This is because potassium is widely distributed in food and the kidneys can reduce urinary potassium excretion when intake falls.

Therefore substantial hypokalaemia from reduced intake usually requires:

Severe or prolonged nutritional deficiency

or another contributing mechanism.

2. Starvation

The original notes correctly identify:

Starvation

as a situation in which oral potassium intake can become sufficiently low to contribute to hypokalaemia.

Patients with prolonged:

Malnutrition.

Anorexia.

Starvation.

may develop depletion of total-body potassium.

Other electrolyte deficiencies, particularly:

Magnesium and phosphate deficiency,

may coexist.

3. Inadequate Parenteral Potassium

Hospitalised patients who cannot eat and receive prolonged intravenous fluids without sufficient potassium replacement may develop:

Hypokalaemia.

This is especially likely when there are simultaneous ongoing potassium losses from:

Urine.

Vomiting.

Diarrhoea.

Nasogastric drainage.

Therefore the original note:

“Parenteral”

refers more accurately to inadequate potassium provision during parenteral therapy.

4. Increased Potassium Loss

Increased potassium loss is one of the most important mechanisms of hypokalaemia.

Losses can occur through:

Gastrointestinal tract

or

Kidneys.

A useful clinical question is therefore:

Is the potassium being lost through the gut or through the urine?

5. Gastrointestinal Potassium Loss

Important gastrointestinal causes include:

Vomiting.

Severe diarrhoea.

Laxative/purgative abuse.

Villous adenoma.

Other causes include prolonged gastrointestinal drainage and some fistulas.

6. Vomiting

The original notes correctly include:

Vomiting.

However, an important physiological point is that hypokalaemia from vomiting is not simply due to large amounts of potassium being lost directly in vomit.

Gastric fluid contains mainly:

Hydrogen ions and chloride.

The major potassium loss occurs secondarily through the:

Kidneys.

7. Why Vomiting Causes Hypokalaemia

Persistent vomiting causes:

Loss of HCl

↓

Metabolic alkalosis

• ●

Volume and chloride depletion

↓

Activation of:

Renin–angiotensin–aldosterone system – RAAS

↓

↑ Aldosterone

↓

↑ Distal sodium reabsorption

↓

↑ Renal K⁺ secretion

↓

Hypokalaemia.

Therefore:

VOMITING → METABOLIC ALKALOSIS + SECONDARY HYPERALDOSTERONISM → RENAL K⁺ LOSS.

8. Severe Diarrhoea

The original notes correctly identify:

Severe diarrhoea

as an important cause.

Intestinal fluid contains significant potassium.

Therefore prolonged high-volume diarrhoea can cause direct:

Gastrointestinal K⁺ loss.

9. Diarrhoea and Acid–Base Balance

Diarrhoea also causes loss of:

Bicarbonate.

Therefore the classic biochemical pattern is:

Hypokalaemia

• ●

Normal-anion-gap metabolic acidosis.

This contrasts with vomiting, which typically produces:

Hypokalaemia + metabolic alkalosis.

10. Purgative or Laxative Abuse

Chronic excessive use of laxatives can produce:

Persistent diarrhoea

and therefore:

Potassium depletion.

Severe laxative abuse may result in substantial electrolyte disturbances and volume depletion.

Therefore:

LAXATIVE ABUSE → DIARRHOEA → GI K⁺ LOSS → HYPOKALAEMIA.

11. Villous Adenoma

A large secretory:

Villous adenoma of the colon or rectum

can produce substantial amounts of watery, electrolyte-rich diarrhoea.

This can cause:

Hypokalaemia.

Volume depletion.

Renal impairment.

The severe secretory syndrome associated with a large villous adenoma is sometimes called:

McKittrick–Wheelock syndrome.

12. Renal Potassium Loss

The kidneys are another major route of excessive potassium loss.

Important renal causes include:

Thiazide diuretics.

Loop diuretics.

Renal tubular disorders.

Mineralocorticoid excess.

Hypomagnesaemia.

13. Thiazide Diuretics

The original notes correctly include:

Thiazides.

Examples include:

Bendroflumethiazide.

Hydrochlorothiazide.

Indapamide.

Thiazides inhibit sodium chloride reabsorption in the:

Distal convoluted tubule.

This increases sodium delivery to the collecting duct.

14. Why Thiazides Cause Hypokalaemia

More sodium reaches the distal nephron.

↓

More sodium enters principal cells through:

ENaC.

↓

The lumen becomes relatively negative.

↓

Potassium secretion increases.

↓

Hypokalaemia.

Volume contraction also activates:

RAAS and aldosterone,

further promoting potassium loss.

15. Loop Diuretics

Loop diuretics such as:

Furosemide

inhibit the:

Na⁺-K⁺-2Cl⁻ cotransporter – NKCC2

in the thick ascending limb of the loop of Henle.

This increases distal sodium delivery and promotes:

Renal potassium excretion.

Therefore:

LOOP DIURETICS → HYPOKALAEMIA.

16. Diuretics and Metabolic Alkalosis

Both loop and thiazide diuretics commonly produce:

Hypokalaemia

and

Metabolic alkalosis.

This occurs through increased distal sodium delivery, volume contraction and increased aldosterone activity.

Therefore:

DIURETIC + LOW K⁺ + METABOLIC ALKALOSIS

is a classic clinical pattern.

17. Renal Tubular Damage

The original notes include:

Renal tubular damage.

Tubular disorders can impair normal electrolyte handling and cause inappropriate urinary potassium loss.

Examples include certain:

Tubulointerstitial diseases.

Drug-induced tubular injury.

Inherited tubular disorders.

The exact acid–base pattern depends on which part of the nephron is affected.

18. Renal Tubular Acidosis

Certain forms of:

Renal tubular acidosis – RTA

are associated with hypokalaemia.

These include:

Type 1 – distal RTA.

Type 2 – proximal RTA.

Both can produce:

Hypokalaemic normal-anion-gap metabolic acidosis.

In contrast:

Type 4 RTA causes hyperkalaemia.

19. Hypomagnesaemia

An important additional cause of persistent renal potassium loss is:

Hypomagnesaemia.

Low magnesium increases renal potassium secretion.

Therefore:

↓ Mg²⁺ → ↑ renal K⁺ wasting → hypokalaemia.

This is particularly important when potassium remains low despite replacement.

20. Refractory Hypokalaemia

A high-yield clinical rule is:

HYPOKALAEMIA THAT DOES NOT CORRECT → CHECK MAGNESIUM.

Potassium replacement may be ineffective until associated magnesium deficiency is also corrected.

21. Endocrine Causes

The original notes identify three important mineralocorticoid-related causes:

Primary hyperaldosteronism.

Cushing syndrome.

Excess liquorice consumption.

These conditions increase renal potassium excretion.

22. Primary Hyperaldosteronism – Conn Syndrome

In primary hyperaldosteronism:

Aldosterone production is excessive and relatively autonomous.

Aldosterone increases sodium reabsorption through ENaC in the collecting duct while increasing:

Potassium secretion

and

Hydrogen ion secretion.

Therefore the classic pattern is:

Hypertension + hypokalaemia + metabolic alkalosis.

23. Renin and Aldosterone in Primary Hyperaldosteronism

Because sodium retention expands extracellular volume, renin secretion becomes suppressed.

Therefore:

Aldosterone ↑

while:

Renin ↓.

This produces an increased:

Aldosterone-to-renin ratio.

However, not every patient with primary aldosteronism is hypokalaemic; many are:

Normokalaemic.

24. Cushing Syndrome

In severe cortisol excess, cortisol can exert:

Mineralocorticoid effects.

This increases sodium retention and promotes renal:

Potassium and hydrogen ion loss.

Therefore severe Cushing syndrome may produce:

Hypertension.

Hypokalaemia.

Metabolic alkalosis.

25. Liquorice

The original notes correctly identify:

Excess liquorice

as a cause of hypokalaemia.

However, liquorice does not simply contain a conventional mineralocorticoid.

Its active component:

Glycyrrhetinic acid

inhibits:

11β-hydroxysteroid dehydrogenase type 2 – 11β-HSD2.

26. Mechanism of Liquorice-Induced Hypokalaemia

Normally 11β-HSD2 converts:

Cortisol → cortisone

within mineralocorticoid-sensitive tissues.

When the enzyme is inhibited:

Cortisol activates mineralocorticoid receptors.

↓

↑ Na⁺ retention

↓

↑ K⁺ and H⁺ excretion

↓

Hypertension + hypokalaemia + metabolic alkalosis.

This resembles mineralocorticoid excess.

27. Redistribution Into Cells

Hypokalaemia does not always mean potassium has been lost from the body.

Sometimes total-body potassium is relatively preserved, but potassium moves:

From extracellular fluid → into cells.

This lowers the measured serum potassium.

Important causes include:

Metabolic alkalosis.

Insulin.

β₂-adrenergic agonists.

Correction of severe megaloblastic anaemia.

Hypothermia.

28. Metabolic Alkalosis

The original notes correctly include:

Metabolic alkalosis.

During alkalosis, potassium tends to shift:

Into cells.

Hydrogen ions move in the opposite direction to help maintain electroneutrality.

Additionally, many causes of metabolic alkalosis, such as vomiting and diuretic therapy, simultaneously cause:

Renal potassium loss.

Therefore hypokalaemia and metabolic alkalosis commonly reinforce one another.

29. Insulin

The original notes correctly identify:

Insulin.

Insulin stimulates:

Na⁺/K⁺-ATPase.

This drives potassium:

From extracellular fluid → into cells.

Therefore insulin lowers serum potassium.

30. Clinical Importance of Insulin

This physiological effect is deliberately used when treating:

Hyperkalaemia.

Intravenous insulin with glucose shifts potassium into cells and temporarily lowers serum K⁺.

Conversely, excessive insulin activity can contribute to:

Hypokalaemia.

31. β-Adrenergic Agonists

The original notes correctly include:

β-adrenergic agonists, particularly β₂ agonists such as:

Salbutamol.

β₂-receptor stimulation increases Na⁺/K⁺-ATPase activity.

Therefore:

Salbutamol → K⁺ moves into cells → serum K⁺ falls.

This is also why nebulised salbutamol can be used as an adjunct in the treatment of:

Hyperkalaemia.

32. Vitamin B12 or Folate Treatment

The original notes include:

Vitamin B12 or folic acid when correcting megaloblastic anaemia.

This is a recognised but less common mechanism.

When severe megaloblastic anaemia is treated, effective erythropoiesis can increase rapidly.

New cells take up:

Potassium.

Therefore serum potassium can transiently fall.

33. Mechanism During Haematological Recovery

Vitamin B12/folate treatment

↓

Rapid increase in erythropoiesis

↓

Increased cellular uptake of K⁺

↓

Transient hypokalaemia.

This is most relevant in patients with severe deficiency undergoing brisk marrow recovery.

34. Hypothermia

The original notes also include:

Hypothermia.

Hypothermia can cause potassium to move:

Into cells

and may increase renal potassium loss.

Therefore serum potassium may fall during significant hypothermia.

An important clinical consideration is that potassium may rise again during:

Rewarming.

35. Clinical Features of Hypokalaemia

Mild hypokalaemia may be:

Asymptomatic.

With increasing severity, patients may develop:

Fatigue.

Muscle weakness.

Muscle cramps.

Constipation or ileus.

Paraesthesiae.

Severe deficiency can cause:

Flaccid paralysis.

Respiratory muscle weakness.

Cardiac arrhythmias.

36. ECG Changes

Hypokalaemia can produce characteristic ECG abnormalities.

These may include:

Flattened or inverted T waves.

ST-segment depression.

Prominent U waves.

Apparent QT/QU prolongation.

Severe hypokalaemia increases susceptibility to:

Atrial and ventricular arrhythmias.

37. Hypokalaemia and Digoxin

Hypokalaemia increases myocardial sensitivity to:

Digoxin.

Therefore a patient receiving digoxin who develops significant hypokalaemia has an increased risk of:

Digoxin toxicity and arrhythmias.

This is particularly important when hypokalaemia is caused by:

Loop or thiazide diuretics.

38. Investigation

The first step is to confirm the potassium abnormality and look for the underlying mechanism.

Useful investigations include:

Serum electrolytes.

Magnesium.

Renal function.

Bicarbonate/acid–base status.

ECG when clinically significant.

If the cause remains uncertain, urinary potassium can help determine whether potassium loss is:

Renal or extrarenal.

39. Urinary Potassium

Conceptually:

Low urinary K⁺ during hypokalaemia

suggests that the kidneys are appropriately conserving potassium.

This points toward:

GI loss, poor intake or intracellular redistribution.

In contrast:

Inappropriately high urinary K⁺

suggests:

Renal potassium wasting.

This may occur with:

Diuretics.

Mineralocorticoid excess.

Renal tubular disorders.

Hypomagnesaemia.

40. Blood Pressure and Acid–Base Status

A particularly useful diagnostic approach is to combine:

Blood pressure

with

Acid–base status.

For example:

Hypokalaemia + metabolic alkalosis + hypertension

suggests:

Mineralocorticoid excess, such as primary aldosteronism.

Hypokalaemia + metabolic alkalosis + normal/low BP

suggests possibilities such as:

Vomiting.

Diuretics.

Bartter syndrome.

Gitelman syndrome.

Hypokalaemia + metabolic acidosis

suggests:

Diarrhoea

or

Type 1/type 2 RTA, among other causes.

41. Treatment Principles

Treatment depends on:

Severity of hypokalaemia.

Symptoms.

ECG abnormalities.

Underlying cause.

Renal function.

Presence of hypomagnesaemia.

The underlying potassium loss or redistribution should be corrected whenever possible.

42. Potassium Replacement

Mild-to-moderate hypokalaemia is often treated with:

Oral potassium replacement.

More severe or symptomatic hypokalaemia may require carefully controlled:

Intravenous potassium replacement

with appropriate monitoring.

Intravenous potassium must be administered cautiously because excessive or rapid administration can cause:

Dangerous hyperkalaemia and cardiac arrhythmias.

43. Correct Magnesium

If hypomagnesaemia is present:

Replace magnesium as well.

Otherwise continued renal potassium wasting can make hypokalaemia:

Difficult or impossible to correct adequately.

44. Causes of Hypokalaemia – Note Form

DECREASED INTAKE:

Starvation/severe malnutrition.

Inadequate potassium during prolonged parenteral therapy.

Usually insufficient alone unless prolonged or combined with other losses.

GI LOSS:

Vomiting.

Severe diarrhoea.

Purgative/laxative abuse.

Villous adenoma.

RENAL LOSS:

Thiazide diuretics.

Loop diuretics.

Renal tubular disease.

Type 1 and type 2 RTA.

Hypomagnesaemia.

ENDOCRINE/MINERALOCORTICOID:

Primary hyperaldosteronism – Conn syndrome.

Cushing syndrome.

Excess liquorice.

REDISTRIBUTION INTO CELLS:

Metabolic alkalosis.

Insulin.

β₂ agonists such as salbutamol.

B12/folate treatment during brisk recovery from severe megaloblastic anaemia.

Hypothermia.

45. Acid–Base Patterns – Note Form

Vomiting:

Hypokalaemia

• ●

Metabolic alkalosis.

Loop/thiazide diuretics:

Hypokalaemia

• ●

Metabolic alkalosis.

Primary hyperaldosteronism:

Hypertension

• ●

Hypokalaemia

• ●

Metabolic alkalosis.

Severe diarrhoea:

Hypokalaemia

• ●

Normal-anion-gap metabolic acidosis.

Type 1 or type 2 RTA:

Hypokalaemia

• ●

Normal-anion-gap metabolic acidosis.

46. Important Clarifications to the Original Notes

The original list is broadly correct.

Reduced oral intake alone is an uncommon cause unless severe or prolonged, such as starvation.

Vomiting causes hypokalaemia mainly through:

Volume/chloride depletion → RAAS activation → aldosterone-mediated renal K⁺ loss, rather than simply direct potassium loss from gastric fluid.

Excess liquorice does not literally act simply as an ingested mineralocorticoid. It inhibits:

11β-HSD2

allowing cortisol to activate mineralocorticoid receptors.

An important addition to the original list is:

Hypomagnesaemia, because it causes renal potassium wasting and is a major reason hypokalaemia may fail to respond to potassium replacement.

Key Clinical Pattern

For rapid recall:

HYPOKALAEMIA = LOW INTAKE, LOSS, OR SHIFT INTO CELLS.

Think:

VOMITING → LOW K⁺ + METABOLIC ALKALOSIS.

DIARRHOEA → LOW K⁺ + NORMAL-GAP METABOLIC ACIDOSIS.

LOOP/THIAZIDE → LOW K⁺ + METABOLIC ALKALOSIS.

CONN → HYPERTENSION + LOW K⁺ + METABOLIC ALKALOSIS.

INSULIN / SALBUTAMOL → K⁺ SHIFTS INTO CELLS.

LOW Mg²⁺ → RENAL K⁺ WASTING → REFRACTORY HYPOKALAEMIA.

For the ECG:

FLAT T WAVES + ST DEPRESSION + PROMINENT U WAVES → THINK HYPOKALAEMIA.

And the particularly useful clinical rule is:

HYPOKALAEMIA THAT WILL NOT CORRECT → CHECK AND REPLACE MAGNESIUM.